Almirall SA LBTSF:OTCPK

*Data is delayed | Exchange | USD
Last | 01/26/24 EDT
9.51UNCH (UNCH)
52 week range
8.85 - 10.18
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close9.51
  • 52 Week High10.18
  • 52 Week High Date09/13/23
  • 52 Week Low8.85
  • 52 Week Low Date06/21/23

Key Stats

  • Market Cap1,819.73M
  • Shares Out209.39M
  • 10 Day Average Volume-
  • Dividend0.20
  • Dividend Yield2.08%
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close9.51
  • 52 Week High10.18
  • 52 Week High Date09/13/23
  • 52 Week Low8.85
  • 52 Week Low Date06/21/23
  • Market Cap1,819.73M
  • Shares Out209.39M
  • 10 Day Average Volume-
  • Dividend0.20
  • Dividend Yield2.08%
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.19
  • P/E (TTM)-49.04
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date05/12/2023
  • Div Amount2.0833
  • Split Date-
  • Split Factor-

Latest On Almirall SA

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals...
Carlos Gallardo Pique
Executive Chairman of the Board, Chief Executive Officer
Thomas McKillop
Vice Chairman of the Board, Other External Director
Michael James McClellan
Chief Financial Officer
Isabel Cristina Gomez
Chief Legal Officer, General Counsel, Non-Member Vice-Secretary of the Board
Address
Ronda General Mitre, 151
Barcelona, BAR
08022
Spain